当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析

金城医药

(300233)

  

流通市值:45.52亿  总市值:47.25亿
流通股本:3.70亿   总股本:3.84亿

金城医药(300233)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.59亿元,每股收益0.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益378431.72万元,未分配利润83605.42万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产521096.62万元,负债142664.91万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入750,421,565.862,736,927,222.731,932,025,566.291,360,240,655.35
营业总成本675,692,157.82,629,657,047.771,891,362,105.71,309,982,354.22
其他经营收益
营业利润77,000,342.3784,216,512.352,885,072.1262,117,305.67
利润总额76,156,474.1978,021,221.1750,577,835.1159,784,979.65
净利润59,010,239.3442,273,760.2333,598,077.7244,966,077.75
每股收益
其他综合收益--1,702,679.15-33,584.91-2,100,000
综合收益总额59,010,239.3440,571,081.0833,564,492.8142,866,077.75
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,174,755,527.312,085,834,424.31,894,736,087.252,005,084,614.41
非流动资产:
非流动资产合计3,036,210,690.673,105,057,247.783,246,316,788.93,278,243,502.33
资产总计5,210,966,217.985,190,891,672.085,141,052,876.155,283,328,116.74
流动负债:
流动负债合计1,255,118,104.921,222,088,936.381,084,641,538.451,093,345,748.84
非流动负债:
非流动负债合计171,530,952.07244,836,970.3339,002,696.18425,709,762.35
负债合计1,426,649,056.991,466,925,906.681,423,644,234.631,519,055,511.19
所有者权益(或股东权益):
归属于母公司股东权益合计3,722,521,275.53,663,385,616.53,650,215,453.433,697,517,562.34
股东权益合计3,784,317,160.993,723,965,765.43,717,408,641.523,764,272,605.55
负债和股东权益合计5,210,966,217.985,190,891,672.085,141,052,876.155,283,328,116.74
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计594,193,338.682,422,456,259.821,771,631,144.061,223,105,757.57
经营活动现金流出小计506,691,341.542,102,816,218.561,587,448,882.491,118,737,846
经营活动产生的现金流量净额87,501,997.14319,640,041.26184,182,261.57104,367,911.57
投资活动产生的现金流量:
投资活动现金流入小计598,452,703.611,481,938,679.73749,919,604.9498,447,840.87
投资活动现金流出小计690,213,567.011,637,894,545.29887,302,639.62525,469,377.05
投资活动产生的现金流量净额-91,760,863.4-155,955,865.56-137,383,034.72-27,021,536.18
筹资活动产生的现金流量:
筹资活动现金流入小计60,000,000137,975,000137,975,000126,975,000
筹资活动现金流出小计105,051,169.53436,674,073.28432,966,504.58390,516,230.81
筹资活动产生的现金流量净额-45,051,169.53-298,699,073.28-294,991,504.58-263,541,230.81
汇率变动对现金及现金等价物的影响-860,202.481,843,586.641,973,205.381,867,868.36
现金及现金等价物净增加额-50,170,238.27-133,171,310.94-246,219,072.35-184,326,987.06
期末现金及现金等价物余额695,142,561.19745,312,799.46632,265,038.05694,157,123.34
补充资料:
现金及现金等价物的净增加额--133,171,310.94--184,326,987.06
TOP↑